ivabradine [orch, phsu]
heart rate [clna]
Variability [cnce]
Patients [podg]
Cardiomyopathy, Dilated [dsyn]
ivabradine [orch, phsu]
Novel [tmco]
Specific [qlco]
heart rate [clna]
lowering [spco]
Agent [chvf]
Event-Free Survival [qnco]
Patients [podg]
Heart failure [dsyn]
objectives [inpr]
Evaluate [ftcn]
ivabradine [orch, phsu]
Domain [ftcn]
Index [inpr]
heart rate [clna]
Variability [cnce]
Patients [podg]
Heart failure [dsyn]
Methods [inpr]
Eight [qnco]
Patients [podg]
Compensated [qlco]
Heart failure [dsyn]
origin [clas]
included [ftcn]
ivabradine [orch, phsu]
treatment [ftcn]
Initiate [idcn]
Late [tmco]
Heart failure [dsyn]
Guidelines [inpr]
heart rate [clna]
Variability [cnce]
H+ [elii]
Obtained [ftcn]
weeks [tmco]
treatment [ftcn]
ivabradine [orch, phsu]
R-R interval [clna]
Standard deviation [qnco]
Normal [qlco]
Normal [qlco]
RR interval [clna]
Standard deviation [qnco]
RR interval [clna]
Standard deviation [qnco]
Normal [qlco]
RR interval [clna]
Segment [spco]
Index [inpr]
Percentage [qnco]
Normal [qlco]
RR interval [clna]
MS [aapp, enzy]
Square [spco]
Root [bpoc]
Square [spco]
Normal [qlco]
Normal [qlco]
RR interval [clna]
baseline [bodm]
treatment [ftcn]
ivabradine [orch, phsu]
weeks [tmco]
treatment [ftcn]
ivabradine [orch, phsu]
Mean Heart Rate [qnco]
P NOS [aapp, imft]
R-R interval [clna]
MS [aapp, enzy]
P NOS [aapp, imft]
MS [aapp, enzy]
P NOS [aapp, imft]
14 7 [qnco]
MS [aapp, enzy]
P NOS [aapp, imft]
Index [inpr]
MS [aapp, enzy]
P NOS [aapp, imft]
P NOS [aapp, imft]
MS [aapp, enzy]
P NOS [aapp, imft]
Improved [qlco]
Sustained [ftcn]
Awake [fndg]
Asleep [fndg]
findings [ftcn]
Suggest [idcn]
treatment [ftcn]
ivabradine [orch, phsu]
heart rate [clna]
Variability [cnce]
Patients [podg]
Heart failure [dsyn]
